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Summary
Objective: The purpose of this study is to investigate stage- and hormone-dependent expression of chondrocyte-derived ezrin-like domain
containing protein (CDEP), a putative guanine nucleotide exchange factor (GEF) for Rho in chondrocytes, and demonstrate the guanine
nucleotide exchange activity of this protein in vitro, as well as the transforming activity in NIH3T3 cells.
Methods: The expression of CDEP mRNA in growth plate chondrocytes in vivo and in vitro was examined by RT-PCR Southern analysis. The
guanine nucleotide exchange activity was determined using a recombinant CDEP peptide containing the DH and PH domains in Sf9 cell
lysates. The transforming activity was examined using NIH3T3 cells transiently transfected with a truncated CDEP cDNA.
Results: CDEP mRNA was expressed at the highest level in the hypertrophic (terminal) stage of chondrocytes in vivo and in vitro. Parathyroid
hormone (PTH) elicited a biphasic increase of CDEP mRNA in chondrocytes. The CDEP mRNA level increased within 1 h, then decreased
nearly to the control level at 3 h. Thereafter the mRNA level started to increase at 6 h, reaching a plateau at 24 h. Dibutyryl cyclic AMP had
a similar effect on CDEP expression in chondrocytes. The dissociation of [3H]GDP from RhoA was stimulated dose-dependently by Sf9 cell
lysates containing the CDEP peptide. Furthermore, transfection of a truncated CDEP cDNA induced focus formation in NIH3T3 cultures.
Conclusions: CDEP is a novel GEF for Rho family GTPases with the transforming activity. CDEP may play a role in mediating or modulating
the action of cAMP-elevating hormones on maturing chondrocytes. © 2001 OsteoArthritis Research Society International
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Parathyroid hormone (PTH) and parathyroid hormone-
related peptide (PTHrP), acting through the same
receptors, play a crucial role during endochondral bone
formation1–3. This action of PTH/PTHrP on chondrocytes is
mediated by cAMP4. The mechanism by which PTH/
PTHrP/cAMP modulates chondrocyte differentiation is
unknown. To address this issue, we established a primary
culture system for human embryo chondrocytes5. In this
system, chondrocytes synthesize cartilage-specific pro-
teins, including type II collagen, matrilin-1 and aggrecan
only in the presence of dibutyryl cyclic AMP (DBcAMP).
Using the subtraction method, we isolated a cDNA for
CDEP (chondrocyte derived ezrin-like domain containing
protein) that was expressed in DBcAMP-exposed, well-
differentiated chondrocytes but not in DBcAMP-free
dedifferentiated cells6. CDEP had the ezrin-like domain in
the amino-terminal region, and DH (Dbl homology) and PH
(pleckstrin homology) domains in the middle region. TheS64DH and PH domains are found in all known members of the
guanine nucleotide exchange factors (GEFs) for Rho-like
GTPase, including Dbl, Ost, Ect2, Lbc, and FGD17,8. Dbl,
Ost, Ect2 and Lbc are oncogene products, whereas FGD1
is the gene responsible for faciogenital dysplasia. The DH
domain catalyses GTP-GDP exchange for Rho proteins,
and the PH domain is necessary for binding to the mem-
brane or cytoskeleton. Furthermore, these domains are
indispensable for the transforming activity of Rho GEF7,8.
In this study, we examined the changes in CDEP expres-
sion during chondrocyte differentiation and the effect of
PTH or cAMP on CDEP mRNA expression in chondrocytes.
Further, we investigated whether CDEP has the guanine
nucleotide exchange activity for RhoA and the transforming
activity in focus formation assays.Materials and methodsSend correspondence to: Dr Y. Kato, Department of Biochemis-
try, Hiroshima University School of Dentistry, Hiroshima 734-8553,
Japan. Fax: +81-82-257-5629; E-mail: ykato@hiroshima-u.ac.jpMATERIALS
Human recombinant PTH[1-84] was supplied from Dr N.
Kubota (Chugai Pharmaceutical Co., Tokyo, Japan).
-Modified Eagle’s medium (-MEM), fetal bovine serum
and DBcAMP were obtained from Sanko Pharmaceutical
Osteoarthritis and Cartilage Vol. 9 Suppl. A S65(Tokyo, Japan), Mitsubishi Kagaku (Tokyo, Japan) and
Sigma Chemical Co. (St Louis, MO), respectively.CULTURES OF CHONDROCYTES AND MRC5 CELLS
Chondrocytes were isolated from the growth plates of
the rib cartilage of 4-week-old male Japanese white rabbits,
as previously described9, The chondrocytes or human
embryonic lung fibroblasts (MRC5) (Riken Gene Bank,
Tsukuba, Japan) were seeded at 1×105 cells per 22.7-mm
plastic tissue culture dish. These cells were maintained in
3 ml of -MEM containing 10% fetal bovine serum, 50 g/
ml of ascorbic acid, 32 units/ml of penicillin and 40 g/ml of
streptomycin.RT-PCR/SOUTHERN BLOT ANALYSIS
The guanidine thiocyanate/cesium trifluoroacetate
method extracted total RNA from cartilage slices or
chondrocyte cultures. Reverse transcriptase-polymerase
chain reaction (RT-PCR) was performed using total RNA as
a template and the oligonucleotide primers. PCR primers
for CDEP, type X collagen, alkaline phosphatase (ALPase),
aggrecan and GAPDH are as follows: 5′-AGTCAGAG
GATGACCTGAGC-3′ and 5′-ACAGCTCGGAAAGGTGA
GGA-3′ for CDEP, 5′-CCCA ACACCAAGACACAGTT-3′
and 5′-ATCACCTTTGATGCCTGGCT-3′ for type X colla-
gen, 5′-AGGCTGGAGATGGACAAGTT-3′ and 5′-TGGTCA
ATCCTGCCTCCTTC-3′ for ALPase, 5′-GGACACCAACG
AGACCTATG-3′ and 5′-CTTCGCCCTCAGTGATGT TC-3′
for aggrecan, as well as 5′-GTCAAGGCTGAGAACGG
GAA-3′ and 5′-T CCACCACCCTGTTGCTGTA for GAPDH.
The PCR products were analysed by electrophoresis on
a 1% agarose gel containing 1 g/ml ethidium bromide.
Some samples were transferred to Hybond-N membranes
(Amersham International plc, Buckinghamshire, UK). A
CDEP cDNA fragment was labelled with [32P]dCTP and
used as a hybridization probe5. The membranes were
washed at 65°C for 30 min with 0.2×SSC containing 0.5%
SDS. The washed membranes were exposed to BioMax
X-ray films (Eastman Kodak Co., Rochester, NY, USA). The
radioactivity was measured using a laser image analyser
(Fujix, BAS 2000).GDP DISSOCIATION ASSAY
A recombinant CDEP peptide was expressed in insect
cells (Sf9) using a baculovirus expression system. A 1035
base fragment of the cDNA containing the DH and PH
domain sequences for CDEP was inserted into the
GST and HA fusion baculovirus transfer vector pV-IKS10.
Parental Sf9 cells or Sf9 cells expressing the CDEP peptide
(1×107 cells/15 cm dish) were harvested 72 h after infec-
tion, and cell lysates were obtained as described pre-
viously10,11. GST-RhoA was expressed in Sf9 cells and
purified using glutatione-Sepharose 4B columns11. The
GEF activity was determined by measuring [3H]GDP
dissociation from GST-RhoA in the in vitro nitrocellulose
binding assay12.FOCUS FORMATION ASSAY
The transforming activity was evaluated in focus
formation assays12,13. Briefly, mouse NIH3T3 cells wereseeded at 1×105 cells per 10-cm dish and maintained in
DMEM with 5% calf serum. The cells were transfected
using lipofectin (QUIAGEN) without or with 10 g of empty
pSVL vector or a vector encording a 5′-truncated CDEP or
an activated c-H-Ras. Foci were observed microscopically
17 days after transfection.ResultsHIGH LEVEL EXPRESSION OF CDEP MRNA IN THE HYPERTROPHIC
STAGE OF CHONDROCYTES IN VITRO AND IN VIVO
To examine the changes in the CDEP-mRNA level during
chondrocyte differentiation, we used sequential slices of
cartilage as described previously2 (R, resting cartilage; G1,
the proliferating zone; G2, the matrix-forming zone; G3, the
hypertrophic zone of the growth plate). CDEP was
expressed at a higher level in the hypertrophic zone than in
any other zones in vivo (Fig. 1). In addition, we established
growth-plate chondrocyte cultures in which the cells
undergo proliferation (day 6), cartilage-matrix synthesis
(days 10–14), hypertrophy (days 14–26) and calcification
(day 26)4. Collagen type X and alkaline phosphatase
(ALPase) were expressed in the hypertrophic stage (Fig.
2). The CDEP mRNA level was low in the proliferating and
matrix-forming stages, and markedly increased in the
hypertrophic and calcifying stages (Fig. 2). The mRNA level
of GAPDH was almost consistent throughout the culture
period.Fig. 1. Expression of CDEP mRNA in the growth plate in vivo. The
growth plate cartilage were divided into three parts (G1, the
proliferating zone; G2, the matrix-forming zone; G3, the hyper-
trophic zone). Total RNA was extracted from resting cartilage (R)
and the growth plate slices (G) and subjected to RT-PCR Southern
analysis for CDEP and RT-PCR analysis for type X collagen,
aggrecan, ALPase and GAPDH.EFFECTS OF PTH AND DBCAMP ON CDEP EXPRESSION IN
CHONDROCYTES AND FIBROBLASTS
The CDEP was expressed at a high level in well-
differentiated chondrocytes exposed to DBcAMP for
several days, but not detectable in dedifferentiated
cartilage cells maintained without DBcAMP6. In this study,
we examined whether PTH, a potent activator of adenylate
cyclase as well as DBcAMP induces CDEP mRNA in dose-,
time- and stage-dependent manners.
In growth-plate chondrocyte cultures exposed to 10−7 M
PTH, the CDEP mRNA level markedly increased within 1 h,
and then decreased to the control level at 3 h. Thereafter, it
increased gradually until 24 h. The high CDEP level was
sustained at least until 48 h (Fig. 3A). This effect could be
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plateau at 10−8 M (Fig. 3B). During the matrix-forming and
hypertrophic stages, PTH increased the CDEP mRNA
level, but not in the proliferating stage (data not shown).
PTHrP[1-34] that binds to a common PTH/PTHrP receptor
also increased CDEP expression in chondrocytes on day
14 (data not shown).
DBcAMP at 1 mM increased the CDEP mRNA level in
chondrocytes on day 14, and the extent of induction was
similar to that obtained with PTH (data not shown).GEF ACTIVITY OF CDEP FOR RHO IN VITRO
A recombinant GST-CDEP peptide containing the DH
and PH domains was expressed in Sf9 cells using a
baculovirus expression system (Fig. 4A). GEF activity was
determined by measuring dissociation of 3H-GDP from
3H-GDP-RhoA bound to nitrocellulose. The dissociation of
3H-GDP from 3H-GDP-RhoA was stimulated by Sf9 cell
lysates containing an N-truncated CDEP fragment
dose-dependently, but not by control lysates (Fig. 4B).TRANSFORMATION OF NIH3T3 CELLS BY EXPRESSION OF AN
N-TRUNCATED CDEP PEPTIDE
Most Rho GEFs can induce malignant transformation
when N-truncated forms of RhoGEF containing the DH and
PH domains are transfected into fibroblasts7,8. However,
the transforming activity of Rho GEF alone is not prominent
in most assays. In this study, an N-truncated form of CDEP
containing the DH and PH domains (Fig. 5A) was
expressed in transiently transfected NIH3T3 cells. In cul-
tures of the CDEP-transfected cells, foci appeared 5–7
days after transfection. The size of focus increased with
time. Activated c-H-Ras also induced focus formation. The
size and morphology of CDEP- and activated c-H-Ras-
transformed cell-foci resembled each other (Fig. 5B). Theaverage number (±SD) of foci 17 days after transfection
was 19±2, 14±2, 6±1 and 3±1 per 10-cm dish for CDEP
cultures, activated c-H-Ras cultures, cultures expressing
the vector alone and mock-transfected cultures, respect-
ively. The foci-like structure formed in the control cultures
appears to represent cellular aggregation.Fig. 2. Expression of CDEP mRNA in growth plate chondrocyte
cultures. Growth plate chondrocytes were seeded at high density
and maintained for 6-26 days as described in Materials and
methods. Total RNA was extracted from the cultures on the days
indicated and subjected to RT-PCR analysis for type X collagen,
ALPase and GAPDH, and RT-PCR Southern analysis for CDEPFig. 3. Effects of PTH on the expression of CDEP mRNA in
cultures of growth plate chondrocytes. A, Chondrocytes in conflu-
ent cultures on day 14 were exposed to 10−7 M PTH[1-84] for
1–48 h before the end of incubation. B, Chondrocyte cultures were
exposed on day 14 to increasing concentrations of PTH[1-84] for
1 h before the end of incubation. Total RNA was extracted from the
cultures and was subjected to RT-PCR analysis for GAPDH and
RT-PCR Southern analysis for CDEP.Discussion
Rho regulates many cell functions including adhesion,
migration, proliferation, differentiation, secretion, and
malignant transformation. Rho is inactivated by Rho GDI
(GDP dissociation inhibitor), activated by Rho GEF and
returns to the inactive form by Rho GAP7,8. In resting cells,
Rho GEFs are usually maintained as an inactive form.
Some Rho GEF proteins are thought to be activated by
protein–protein interactions or phosphorylation in response
to extracellular stimuli7,8. On the other hand, N-truncated
forms of Rho GEFs containing the DH and PH domains
show constitutive GEF activity, perhaps because of the
absence of the inhibitory action of the N-terminal region7,8.
We demonstrated here that an N-truncated form of CDEP
has the Rho GEF activity in vitro. It is noteworthy that the
N-terminal region of CDEP contains an ezrin-like domain.
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GDI complex before the activation of Rho by Rho GEF14.
Rho GDI renders most of Rho proteins cytosolic and blocks
the GEF action. Thus the ezrin-like domain in CDEP may
be useful to release Rho GDI form the complex in vivo. In
other words, CDEP could be more potent in activating Rho
in vivo than other Rho GEFs.
Another significant finding of this study is the transfor-
mation of NIH3T3 cells transfected with a truncated form of
CDEP. Previous studies have shown that several Rho GEF
fragments containing the DH and PH domains can induce
transformation of NIH3T3 cells, although the transforming
activity of Rho GEF is usually very low. Fortunately, we
could observe the transfoming activity of the truncated
CDEP in focus formation assays. Perhaps the constitutively
active form of CDEP induced transformation via the
activation of Rho family members.
The importance of CDEP in chondrocyte differentiation is
also suggested by the findings that CDEP was expressed
stage-dependently, and that PTH/PTHrp and cAMP
induced CDEP expression within 1 h. DBcAMP and PTH
elicited a similar pattern of changes in CDEP mRNA
expression, indicating that PTH/PTHrP induces CDEP via
an increase in the intracellular cAMP concentration.
There have been no studies reporting that hormones or
growth factors enhance Rho GEF mRNA expression,
although some extracellular stimuli have been shown to
increase the enzyme activity of pre-existing Rho GEF
proteins7,8. Our findings suggest that hormones/growth
factors/cAMP can modulate differentiation of some cells
such as chondrocytes through an increase in the protein
level of some Rho GEFs including CDEP.
PTH/PTHrp is crucial for chondrocyte differentiation
particularly at the terminal (hypertrophic) stage1–3. The
CDEP expression was up-regulated in the hypertrophic
stage, and further enhanced by PTH/PTHrP. These findings
suggest that CDEP is involved in the control of chondrocyte
phenotypic expression as a downstream regulator of the
PTH/PTHrP/cAMP signalling pathway. However, CDEP is
ubiquitously expressed in many tissues in vivo6, and
DBcAMP induced CDEP in fibroblasts (unpublished data).
Thus CDEP may be involved in mediating or modulating
the action of cAMP-elevating hormones in various
cells.Fig. 4. Schematic representation of the CDEP construct used in
the GDP dissociation assay (A), and dose-dependent effects of the
Sf9 cell lysates containing CDEP on [3H]GDP dissociation from
RhoA (B). Increasing amounts of Sf9 cell lysates containing a
CDEP or control lysates were incubated with RhoA bound
[3H]GDP for 20 min. The level of GDP dissociation was determined
by measuring [3H]GDP bound to nitrocellulose filters.Fig. 5. Schematic representation of the CDEP construct used in
focus formation assays (A), and the transforming acitivity of CDEP
in NIH3T3 cells (B). NIH3T3 cells were not transfected or trans-
fected using lipofectin with 10 g of empty pSVL vector or a vector
encording a 5′-truncated CDEP or an activated c-H-Ras. Foci were
observed microscopically 17 days after transfection.References
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